Welcome to CREANT!

CREANT is the acronym of the Center for Radiopharmaceuticals Antwerp.

What we do

We create innovative radiopharmaceutical solutions that will improve the lives of cancer patients around the globe.

Discover our research

Our mission

CREANT’s mission is to ensure that the right cancer treatment is given to the right patient at the right time. By developing radiopharmaceuticals that target specific cancer markers we aim to provide an individually tailored therapeutic intervention.

Meet the team

CREANT is driven by the enthousiasm of a large number of people.

Meet the team 

Creating innovative radiopharmaceuticals for tomorrow’s theranostics.

News

Postdoctoral researcher nanoparticle-based radioligands for theranostic oncology applications

We are excited to announce an open vacancy for a full-time (100%) postdoctoral researcher in the field of nanoparticle-based radioligands for theranostic oncology applications!

READ MORE

Impressions of our mini-symposium on Cancer Radiotheranostics

Take a look at some impressions of our recent mini-symposium on radiotheranostics! A big thank you to all the incredible speakers who shared their expertise and insights on this transformative field. During this symposium Karuna Adhikari successfully defended her PhD dissertation!

READ MORE

Vacancy postdoctoral researcher for the development of radiopharmaceuticals

We are excited to announce an open vacancy for a full-time (100%) postdoctoral researcher in the field of radiopharmacy/radiochemistry!

READ MORE

Our partners

University of Antwerp
Molecular Imaging Center Antwerp (MICA)
Antwerp University Hospital (UZA)